white-logo
17 - 19 NOVEMBER 2026 | BARCELONA, SPAIN
HYATT REGENCY BARCELONA TOWER | BOOTH 3C

19th EBF Open Symposium

SCHEDULE A MEETING
Hero BG PharmSci25
event icon

Advancing bioanalytical science requires collaboration, innovation, and the exchange of best practices—making EBF a key forum for the industry. Meet with BioAgilytix to learn how our scientific expertise and bioanalytical solutions help generate the high-quality data needed to move drug development forward.

Expertice

BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. We offer the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing in a GxP environment. Our lab services include immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, eliminating the need for multiple providers, ensuring efficient data delivery for your therapeutic study.

Barcelona, Spain

Details

noun-calendar-5687483 1 1
17 - 19 November 2026
noun-location-5687484 1 1
Booth 3C
Hyatt Regency Barcelona Tower
Barcelona, Spain

Presentations

Janett Schwarz at BioAgilytix

Janett Schwarz, PhD

Scientific Operations

BioAgilytix

Fit-for-Purpose Implementation of a Generic Preclinical PK Assay: Lessons from Platform Transfer and Troubleshooting

Tuesday 17 November

11:50 - 12:10

Session 2: Smarter Workflows: From Implementation to Scientific Confidence

Lara Duchstein at BioAgilytix

Lara Duchstein

Scientific Operations

BioAgilytix

Considering DNA & RNA Extraction for PCR-Based Assay Validations

Tuesday 17 November

17:40 – 18:00

Session 9: New Technologies and Emerging Modalities in Bioanalysis: PCR 

Dave_Beyerlein (2)

Dave Beyerlein

Scientific Operations

BioAgilytix

Cross-Platform Evaluation of Total Antibody and Total ADC PK: LBA versus LC-MS

Wednesday 18 November

12:20 – 12:40

Session 13: BioA Clinic

MinhDang2026_edit (1) (1)-1

Minh Dang, PhD

Scientific Operations

BioAgilytix

Responding to Evolving Clinical Needs: A Collaborative Journey to an Ultra-Sensitive PK Assay

Thursday 19 November

11:10 – 11:30

Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis

Posters

SussanGhassabian_edit-1

Sussan Ghassabian, PhD

Scientific Operations

BioAgilytix

Matrix effect evaluation for endogenous analytes: Surrogate matrix approach for LC-MS-based assays

Courtney Zych

Courtney Zych

Scientific Operations

BioAgilytix

Matrix effect evaluation for endogenous analytes: Surrogate matrix approach for LC-MS-based assays

G63A3365

The European Bioanalysis Forum (EBF) provides a platform for scientists to exchange ideas, share best practices, and discuss the latest advances in bioanalysis. The forum brings together pharmaceutical companies and CROs to address scientific, technological, and regulatory challenges shaping the future of drug development.

Partner with us

Scientific Expertise Built Around Analytical Confidence

At BioAgilytix, every development program begins with a tailored analytical strategy designed to generate reliable, regulatory-ready data. Our scientific teams partner closely with sponsors to navigate complex analytical challenges while supporting critical development decisions.

Global Scale. Local Expertise.

With laboratories across North America, Europe, and Australia, BioAgilytix combines global operational scale with localized scientific support. From early discovery through commercialization, our integrated laboratory network helps sponsors move programs forward with confidence.

Let’s Connect at EBF

Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline support for your therapeutic program.
 

© Copyright 2026 BioAgilytix Labs. All rights reserved.

Privacy Policy

Terms Of Use

icon-linkedin-footer youtube-footer